Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vitamin B>4< |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Riboflavin |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B>12b< |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing para-aminobenzoic acid (medicinal product) |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Niacinamide |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folic acid |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thioctic acid |
Is a |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pantothenic acid |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Biotin |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B group poisoning |
Causative agent |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
accidentel forgiftning med nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
tilsigtet forgiftning med nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
forgiftning med nicotinsyrederivat, uvist med hvilken hensigt |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
bivirkning af vitamin B-gruppe |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Nicotinic acid adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Vitamin B12 preparation adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Hydroxocobalamin adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Cyanocobalamin adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinamide adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
bivirkning af præparat indeholdende B-kompleks-vitamin |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
Inositol adverse reaction (disorder) |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine preparation adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine preparation adverse reaction |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
overdosis af B-vitamin-gruppe |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
1 |
overdosis af nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
accidentel overdosis af nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
tilsigtet overdosis af nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
overdosis af nicotinsyrederivat, uvist med hvilken hensigt |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
forgiftning med nicotinsyrederivat |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Levocarnitine |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid adverse reaction (disorder) |
Causative agent |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Choline bitartrate (substance) |
Is a |
True |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing inositol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing choline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 17,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 35 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 7,5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 15 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 30 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
B-vitamin-gruppe-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely pyridoxine (as pyridoxine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Pyridoxine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Thiamine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
B + C-vitaminer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
stærk B + C-vitamin injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing potassium aminobenzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
B-vitamin-kombination tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
stærk B-vitamin-kombination tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
præparat indeholdende B-kompleks-vitamin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing folinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
præparat indeholdende pyridoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing thiamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
præparat indeholdende pyridoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
thiaminhydrochloridpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
thiaminmononitratpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid derivatives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing riboflavin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
folinsyre 50 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 50mg/mL injection solution 8mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 50mg/mL injection solution 18mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing lovastatin and nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
pyridoxinhydrochlorid 100 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
pyridoxinhydrochlorid 100 mg/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
pyridoxinhydrochlorid 100 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
levofolinsyre 50 mg/5 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
startpakning bestående af nicotinsyre 375 mg tablet med modificeret udløsning + nicotinsyre 500 mg tablet med modificeret udløsning + nicotinsyre 750 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
nicotinsyre 500 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
nicotinsyre 750 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
nicotinsyre 1000 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Nicotinic acid compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
krystallinsk hydroxocobalamin-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing hydroxocobalamin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
hydroxocobalamin 1 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 50 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vitamin B and/or vitamin B derivative (substance) |
Inferred relationship |
Some |
|